ConvaTec Group PLC (LSE:CTEC) - Share price - Overview

Stock Report

ConvaTec Group PLC CTEC

Last Price
GBX242.55

Day Change
2.85|1.19%

As of 16/01/2017
15:25:42 GMT | GBX
Minimum 15 Minutes Delay.

Last Close239.70p
Day Range240.20 - 243.80
Mkt Cap4.68Bil
52-Wk Range213.00 - 259.75
Yield %0.00
ISINGB00BD3VFW73
Volume359,182
P/E-87.88
P/S4.38
P/CF72.10

Share Price

Total Returns 13/01/2017

 Chg (%)  
More ...
ConvaTec Group PLC-2.96 
FTSE 100 TR GBP5.35
 
Financials
201320142015
More ...
Income Statement
Turnover1,087.651,053.341,080.24
Operating Profit196.72132.96150.80
Net Profit9.72-77.26-61.13
Reported EPS0.50-3.95-3.14
Balance Sheet
Current Assets527.94480.49513.74
Non Current Assets2,180.942,041.871,935.68
Total Assets2,708.872,522.352,449.41
Current Liabilities247.54213.76193.77
Total Liabilities2,680.072,664.532,720.80
Total Equity28.80-142.18-271.39
Cash Flow
Operating Cash Flow307.42278.73262.07
Net Change in Cash92.29-9.1136.06
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016157.347.25-33.04---
2017317.2414.4799.4516.570.175.062.11

Company Profile

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.
 

Sector

Medical Devices

Market Position

95 of 1849 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE All Share

Outlook

(-)

Next Event 27/02/2017

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)16.5717.1916.45
Div Yld (E)2.111.904.01
PEG (E)0.171.470.70
ROCE26.5230.5698.67
Op Mrgn11.98-20.13-16.27
EPS Grwth99.4533.3324.12
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanSir Christopher Gent
Chief Executive OfficerMr. Paul Moraviec
Chief Financial OfficerNigel Clerkin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.